Holen Sie sich die Stockscreener-App
0.9323
0.79%
0.0073
Vorhandelsmarkt:
.93
-0.0023
-0.25%
Schlusskurs vom Vortag:
$0.925
Offen:
$0.94
24-Stunden-Volumen:
51,796
Relative Volume:
0.01
Marktkapitalisierung:
$2.41M
Einnahmen:
$3.29M
Nettoeinkommen (Verlust:
$-3.09M
KGV:
-0.758
EPS:
-1.23
Netto-Cashflow:
$-2.46M
1W Leistung:
-4.38%
1M Leistung:
+3.01%
6M Leistung:
-78.76%
1J Leistung:
-88.70%
1-Tages-Spanne:
$0.925
$0.9404
1-Wochen-Bereich:
$0.74
$1.08
52-Wochen-Spanne:
$0.6669
$16.10
Nanovibronix Inc Stock (NAOV) Company Profile
Firmenname
Nanovibronix Inc
Sektor
Branche
Telefon
(914) 233-3004
Adresse
969 PRUITT AVE,, TYLER
Vergleichen Sie NAOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.9323 | 2.39M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Nanovibronix Inc Aktie (NAOV) Neueste Nachrichten
What drives NanoVibronix Inc. stock priceRecord-breaking gains - Autocar Professional
What analysts say about NanoVibronix Inc. stockBreakthrough investment results - Autocar Professional
NanoVibronix Inc (NAOV) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com
NanoVibronix Secures $8 Million Through Securities Agreement - AInvest
Why NanoVibronix Inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser
Nanovibronix (NASDAQ:NAOV) Stock Price Down 2.8% – Should You Sell? - Defense World
How NanoVibronix Inc. stock performs during market volatilityCapital Growth Picks - Newser
NanoVibronix Inc. Stock Analysis and ForecastExceptional growth trajectory - jammulinksnews.com
Is NanoVibronix Inc. a good long term investmentFree Bull & Bear Market Updates - jammulinksnews.com
NanoVibronix's $50M Financing: A Strategic Catalyst for Scalable Growth in High-Margin Medical Tech - AInvest
NanoVibronix Secures $50 Million Financing for Preferred Stock - AInvest
why nanovibronix inc. stock attracts strong analyst attentionTriple Digit Return Forecasts - Newser
NanoVibronix shareholders approve reverse stock split proposal at special meeting - Investing.com Australia
NanoVibronix Approves Reverse Stock Split Proposal - TipRanks
NanoVibronix enters into $50M financing agreement - MassDevice
Will NanoVibronix Inc. stock benefit from AI tech trendsFree Risk Assessment Services - Newser
NanoVibronix Announces Financing of up to $50 Million Private Pl - GuruFocus
NanoVibronix secures $8 million in funding, with potential for more - Investing.com
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock - Business Wire
What makes NanoVibronix Inc. stock price move sharplyCapital Protected Stock Selections - beatles.ru
NanoVibronix Adjourns Special Meeting Due to Quorum - The Globe and Mail
NanoVibronix adjourns special meeting due to lack of quorum, reschedules vote - Investing.com Australia
NanoVibronix corrects Series G Preferred Stock floor price in charter filing - Investing.com India
NanoVibronix Announces ENvue Drive -- First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation | NAOV Stock News - GuruFocus
NanoVibronix has a next-gen robotic system under development - MassDevice
NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement | NAOV Stock News - GuruFocus
NAOV’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Finanzdaten der Nanovibronix Inc-Aktie (NAOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):